Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J J M van Dongen

Flow Cytometric Immunobead Assay for Fast and Easy Detection of PML–RARA Fusion Proteins for the Diagnosis of Acute Promyelocytic Leukemia

Leukemia

English

EuroFlow Standardization of Flow Cytometer Instrument Settings and Immunophenotyping Protocols

English

Highly Sensitive MRD Tests for ALL Based on the IKZF1 Δ3–6 Microdeletion

English

Clinical Significance of Flowcytometric Minimal Residual Disease Detection in Pediatric Acute Myeloid Leukemia Patients Treated According to the DCOG ANLL97/MRC AML12 Protocol

English

Correction of B-Cell Development in BTK-Deficient Mice Using Lentiviral Vectors With Codon-Optimized Human BTK

English

Comparative Analysis of T-Cell Receptor Gene Rearrangements at Diagnosis and Relapse of T-Cell Acute Lymphoblastic Leukemia (T-All) Shows High Stability of Clonal Markers for Monitoring of Minimal Residual Disease and Reveals the Occurrence of Second T-All

English

Non-Specific Amplification of Patient-Specific Ig/TCR Gene Rearrangements Depends on the Time Point During Therapy: Implications for Minimal Residual Disease Monitoring

English

High CD33-antigen Loads in Peripheral Blood Limit the Efficacy of Gemtuzumab Ozogamicin (Mylotarg®) Treatment in Acute Myeloid Leukemia Patients

English

DNA Microarrays for Comparison of Gene Expression Profiles Between Diagnosis and Relapse in Precursor-B Acute Lymphoblastic Leukemia: Choice of Technique and Purification Influence the Identification of Potential Diagnostic Markers

English

CALM-AF10+ T-All Expression Profiles Are Characterized by Overexpression of HOXA and BMI1 Oncogenes

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J J M van Dongen

Flow Cytometric Immunobead Assay for Fast and Easy Detection of PML–RARA Fusion Proteins for the Diagnosis of Acute Promyelocytic Leukemia

EuroFlow Standardization of Flow Cytometer Instrument Settings and Immunophenotyping Protocols

Highly Sensitive MRD Tests for ALL Based on the IKZF1 Δ3–6 Microdeletion

Clinical Significance of Flowcytometric Minimal Residual Disease Detection in Pediatric Acute Myeloid Leukemia Patients Treated According to the DCOG ANLL97/MRC AML12 Protocol

Correction of B-Cell Development in BTK-Deficient Mice Using Lentiviral Vectors With Codon-Optimized Human BTK

Comparative Analysis of T-Cell Receptor Gene Rearrangements at Diagnosis and Relapse of T-Cell Acute Lymphoblastic Leukemia (T-All) Shows High Stability of Clonal Markers for Monitoring of Minimal Residual Disease and Reveals the Occurrence of Second T-All

Non-Specific Amplification of Patient-Specific Ig/TCR Gene Rearrangements Depends on the Time Point During Therapy: Implications for Minimal Residual Disease Monitoring

High CD33-antigen Loads in Peripheral Blood Limit the Efficacy of Gemtuzumab Ozogamicin (Mylotarg®) Treatment in Acute Myeloid Leukemia Patients

DNA Microarrays for Comparison of Gene Expression Profiles Between Diagnosis and Relapse in Precursor-B Acute Lymphoblastic Leukemia: Choice of Technique and Purification Influence the Identification of Potential Diagnostic Markers

CALM-AF10+ T-All Expression Profiles Are Characterized by Overexpression of HOXA and BMI1 Oncogenes